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Abstract: A diastereoselective synthesis of the pyrrolizidine alkaloid, (+)-1-epiaustraline 
has been achieved via a diastereoselective syn-dihydroxylation of a pyrrolo[1,2-c]oxazol-
3-one precursor that was readily prepared by a RCM reaction.  Attempts to extend this 
methodology to the synthesis of australine were not successful since the final pyrrolidine 
ring closure to produce the desired pyrrolizidine of the target molecule was not 
productive.  
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Alexine (1) was the first alkaloid to be isolated with the 3-hydroxymethyl-2,3,5,6,7,7a-
hexahydro-1H-pyrrolizine-1,2,7-triol structure in 1988.1 In the same year its 7a-epimer, 
australine (2), was isolated from the seeds of Castanospermum australe.2  Later reports 
described the isolation of other epimers of 2 from these seeds, including 1-epiaustraline 
3.3,4 These alkaloids have been shown to have glycosidase inhibitory activities2,3c,4 and 
other biological studies have revealed the potential of these and related polyhydroxylated 
pyrrolizidines as antiviral and anti-retroviral agents.5  These interesting biological 
properties coupled with the polyfunctional and stereochemically rich nature of these 
compounds have attracted the attention of synthetic chemists resulting in the total 
synthesis of alexine,6 and its epimers,6,7 australine,8 and its epimers,7-11 and casuarine.12  
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Figure 1.  Structures of 3-hydroxymethyl pyrrolizidine 
  
In 2003 we reported a new and potentially general synthetic methodology for the 
synthesis of austaline and its epimers using aminolysis of a chiral vinyl epoxide and 
RCM as key reactions.11  We demonstrated the viability of this synthestic methodology 
3 
with the asymmetric synthesis of (-)-7-epiaustaline  and (+)-1,7-diepiaustraline.11  We 
report here, as an extension of this work, the synthesis of (+)-1-epi-australine and our 
attempts to prepare australine.  These target molecules required that the starting vinyl 
epoxide 4 had the cis-[(3R, 4S)] stereochemistry rather than the trans-[(3R, 4R)] 
stereochemistry used by us previously and it was of interest to examine the effect of this 
stereochemical difference on the diastereoselectivities of the reactions leading to our 
target molecules.  
The starting vinyl epoxide (-)-(3R, 4S)-4 was prepared from the corresponding Sharpless 
epoxy alcohol (82 % ee from 1H NMR analysis of its Mosher ester, see experimental 
section) via Swern oxidation followed by a Wittig-olefination reaction.11,13  A solution of 
the vinyl epoxide (-)-4 and the (S)-allylamine 514 (1.4 equiv, ca 99% ee) in acetonitrile 
was heated at 120 oC in a sealed tube using LiOTf (1.5 equiv) as a catalyst for 3 d.   This 
gave a mixture of two diastereomeric products.  Separation by PTLC gave the desired 
amino alcohol (+)-6 in 62% yield and its diastereomer (structure not shown but referred 
to as compound 6' in the experimental section) in 17% yield that arises from the reaction 
of ent-4 with 5. The amino-alcohol (+)-6 was converted to the diastereomerically pure 2-
oxazolidinone derivative (+)-7 in 94% yield using triphosgene under basic conditions.11,15    
The minor diastereomeric amino-alcohol was converted to its corresponding 2-
oxazolidinone derivative in 69% yield.  In their 1H NMR specta, J4,5 for both 2-
oxazolidinones was 7.5 Hz, while the NOESY spectra of these compounds showed strong 
cross peaks between H-4 and the exo-cyclic methylenes at C-5 (see Scheme 1 for details).  
This was consistent with both 2-oxazolidinones having the C-4, C-5 trans-
stereochemistry which would arise from an SN2 ring opening of 4 or ent-4 with 5.       
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Scheme 1. Reagents and conditions: a) LiOTf, CH3CN, 120 
oC, sealed tube, 72 h; b) 
triphosgene, Et3N, DCM, 0 
oC, 2.5 h; c) Grubbs’ catalyst I, DCM, reflux, 3 d; d) 
K2OsO4
.2H2O, NMO, acetone, H2O, RT, 21 h; e) Ac2O, pyridine, RT, 23 h; f) DDQ, DCM, 
H2O, RT, 5.5 h; g) NaOH, EtOH, 70 
oC, sealed tube, 37 h; h) DIAD, PPh3, pyridine, 0 
oC, 4 h 
then RT 3 h; i) PdCl2, H2, MeOH, RT, 1.5 h; j) Ac2O, pyridine, RT, 22 h; k) Amberlyst A-26 
(OH-form) resin, MeOH, RT, 2 h. 
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The RCM of 7 using standard conditions, 5-10 mol % of Grubbs I catalyst 
(benzylidenebis(tricyclohexylphosphine)ruthenium dichloride) in refluxing CH2Cl2 at high 
dilution (~4 mM) for 20 h, gave low conversion to the desired 2,5-dihydropyrrole (-)-8. 
However, by initiating the reaction using 22 mol% Grubbs I catalyst and then adding a 
further 9 mol% catalyst after 25 h, (-)-8 could be isolated in 97% yield after a total of 42 h of 
heating at reflux.16,17   Compound (-)-8 was treated with 5 mol % K2OsO4.2H2O and NMO 
(2.1 equiv),11,13 to effect syn-dihydroxylation (DH) of the double bond, giving diol (-)-9 in 
good yield (85%).  A small amount (< 5%) of the C-6, C-7 di-epimeric diol was also formed 
but was readily separated by column chromatography. The stereochemistry of diol 9 was that 
expected from our previous studies with osmylation occurring from the concave face of the 
2-oxazolidinone 8.11,17  This stereochemistry was evident from NOESY studies on its acetate 
10 that showed significant cross peaks between H-6 and the exo-cyclic methylene at C-5 and 
between H-6 and H-7a. The absolute stereochemistry assigned to 9 was unequivocally 
confirmed by its conversion to (-)-1-epiaustraline (3).  
Attempts to deprotect the primary PMB ether in 9 under oxidative conditions with DDQ18 
gave a poor yield of the desired primary alcohol due to the formation of several other 
products that could not be structurally identified.  The diacetate derivative 10 however was 
smoothly converted to the primary alcohol 11 in 63% yield.  Compound 11 was then 
converted to the pyrrolizidine-tetraacetate 15 in three synthetic steps.   Base hydrolysis of 11 
followed by ion-exchange chromatography gave 12 which was cyclized to the desired 
pyrrolizidine ring system under Mitsunobu conditions12,19 in pyridine at 0 oC.  The crude 
reaction mixture was then treated under hydrogenolysis conditions12,13,20 and then 
peracetylation gave the pyrrolizidine-tetraacetate 15 in 23% over yield from 11.  Finally, 
6 
methoxide catalysed removal of the acetates of 15 gave (+)-1-epiaustraline (3) in quantitative 
yield. This sample had identical spectral characteristics to those reported in the literature for 
(+)-3,7c,10 and its specific rotation ([]D25 +14.3 (c 1.1, H2O)) closely matched that previously 
reported (lit.10a ([]D25 +13.695 (c 1.72, H2O)). 
Scheme 2 outlines our attempted synthesis of australine (2).  This synthesis required 
inversion of the stereochemistry at C-7 in the pyrrolo[1,2-c]oxazol-3-one 9.   Thus 9 was 
converted to its cyclic-sulfate 16 using thionyl chloride followed by oxidation of the resulting 
cyclic sulfite with catalytic ruthenium tetraoxide (88% yield for the two-step conversion).11,21 
Nucleophilic ring opening of the S,S-dioxo-dioxathiole ring of 16 with cesium 
benzoate,11,21,22 followed by an acidic work up gave a 73 : 27 mixture of regioisomeric 
benzoates in 88% yield. The regioisomers were readily separated by column chromatography 
as their acetate derivatives.  In this way the acetate 18 of the major regioisomer could be 
obtained in 66% yield while the acetate of the minor regioisomer was isolated in 25% yield.  
The structure of the major regioisomer 18 was established by NOESY experiments which 
showed significant cross peaks between H-6 the exo-cyclic methylene at C-5 and between H-
6 and H-7a (See Scheme 2 for proton numbering).  The modest regioselectivity found in the 
ring opening of 16 is in stark contrast to that of 1-epi-16 which gave less than 5% of the other 
regioisomer resulting from attack of benzoate anion at C-6.11  While, nucleophilic attack on 
16 would be expected to occur preferentially at C-7, since backside attack at C-6 would be 
more sterically demanding due to the -C-5 benzyloxymethyl substituent, the configuration 
at C-1 also clearly influences the regiochemistry of ring-opening.    Thus the -orientation of 
the C-1 substituent in 16 must be responsible for the reduced regioselectivity found in the 
ring opening of 16.  Oxidative removal of the primary PMB ether in 18 using DDQ gave the 
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corresponding primary alcohol 19 in 67% yield. Base hydrolysis of the esters and the 
oxazolidinone ring of 19 gave the amino tetrol 20 in 76% yield.  Attempted cyclization of 20 
under Mitsunobu conditions proved problematic and hydrogenolysis of the crude reaction 
mixture and then peracetylation gave a mixture from which only the hexaacetate 21 could be 
isolated in low yield [12%, MS (ES +ve) m/z 460 (M+H+, 27%)].  None of the desired 
peracetylated pyrrolizidine product could be detected.  While we have always had poor yields 
for this type of cyclization reaction,11,16 this is the first time it has not been successful.   
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Scheme 2. Reagents and conditions: a) (i) SOCl2, Et3N, DCM, 0 
oC, 30 min; (ii) 
RuCl3.3H2O, NaIO4, CCl4:CH3CN:H2O = 2:2:3, RT, 2 h; b) (i) PhCOOH, Cs2CO3, DMF, 
40 oC, 23 h; (ii) H2SO4 (conc.), THF, H2O, RT, 18 h; c) Ac2O, pyridine, RT, 23 h; d) 
DDQ, DCM, H2O, RT, 2 h; e) NaOH, EtOH, 70 
oC, 19 h; f) DIAD, PPh3, THF, 0 
oC, 3 h 
then RT, 3 h; g) PdCl2, H2, MeOH, RT, 1 h; h) Ac2O, pyridine, RT, 15 h. 
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In summary, we have developed diastereoselective synthesis of the pyrrolizidine alkaloid, 
(+)-1-epi-australine via a diastereoselective syn-dihydroxylation of a pyrrolo[1,2-
c]oxazol-3-one precursor that was readily prepared by a RCM reaction.  Attempts to 
extend this methodology to the synthesis of australine were not successful since the final 
pyrrolidine ring closure to produce the desired pyrrolizidine of the target molecule was 
not productive.  
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Experimental Section 
List of Abbreviations: ArH: Aromatic protons of PMB, Ar*H: Aromatic protons of Bn 
or Ph, BzH: Aromatic protons of Bz, ArCH2: CH2 of PMB, Ar*CH2: CH2 of Bn, ArC: 
Quaternary aromatic carbons of PMB, Ar*C: Quaternary aromatic carbons of Bn, ArCH: 
Aromatic CH carbons of PMB, Ar*CH: Aromatic CH carbons of Bn, BzCH: Aromatic 
CH carbons of Bz 
General Methods. All reactions were carried out under an atmosphere of nitrogen. All 
NMR spectra were obtained as a CDCl3 solution at 300 MHz (
1H NMR) or 75 MHz (13C 
NMR) unless otherwise stated and were referenced to the relevant solvent peak. 13C 
NMR assignments were made from DEPT experiments. Silica gel chromatography was 
performed using Merck GF 254 flash silica gel packed by the slurry method. Small-scale 
separations (<2.0 g) were performed using either a 10 or 20 mm diameter column, and 
large-scale separations (>2.0 g) were performed using either a 30 or 50 mm diameter 
column, each with the stated solvent system. Specific rotations were measured using a 10 
or a 50 mm cell, and the values quoted were an average of 5-10 measurements. They are 
reported by the following convention: optical rotation [10-1.deg.cm3.g-1] (concentration, 
solvent). Acidic ion-exchange chromatography was performed using DOWEX 50WX8-
50 acidic cation exchange resin, packed by the slurry method in 10 mm diameter column. 
In all cases the compounds were applied as their HCl salts dissolved in distilled water. 
The column was first eluted with water (100 mL) and then eluted with 14% ammonia 
solution (w/w). In all cases, HRMS (exact masses) were obtained on lieu of elemental 
analysis, and 1H and 13C NMR spectroscopy were used as criteria for purity.  
 
Synthesis of (-)-6-(4-Methoxyphenyl)methoxy-3R,4S-epoxy-1-hexene (4) 
Step 1: 5-(4-Methoxyphenyl)methoxy-2Z-penten-1-ol. To the solution of 1-(4’-
methoxy)benzyloxy-3-butyne (431 mg, 1.96 mmol) and quinoline (329 mg, 2.55 mmol) 
was added Pd/CaCO3 (35.8 mg). The mixture was stirred at RT under a nitrogen 
atmosphere for 1.5 h. The mixture was then filtered through celite before the filtrate was 
washed with 1M HCl (3x). The organic portion was dried with MgSO4, filtered and 
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evaporated to dryness in vacuo. Chromatography of the residue eluting with 
EtOAc/petrol (0%-50%) gave the title compound (396 mg, 91%). 1H NMR  7.22 (d, 2H, 
J 8.4 Hz, ArH), 6.85 (d, 2H, J 8.7 Hz, ArH), 5.73 (dt, 1H, J 10.8, 7.2 Hz, H-2), 5.53 (dt, 
1H, J 10.8, 8.1 Hz, H-3), 4.41 (s, 2H, ArCH2), 4.06 (d, 2H, J 6.9 Hz, H-1), 3.75 (s, 3H, 
OMe), 3.43 (t, 2H, J 6.0 Hz, H-5), 3.08 (bs, 1H, OH), 2.35 (td, 2H, J 7.2, 6.6 Hz, H-4); 
13C NMR  158.9 (ArC), 130.7 (CH-2), 129.7 (ArC), 129.1 (ArCH), 128.7 (CH-3), 113.5 
(ArCH), 72.4 (ArCH2), 68.6 (CH2-5), 57.4 (CH2-1), 54.9 (OMe), 27.7 (CH2-4); MS (CI 
+ve) m/z 222 (M+); HRMS (CI +ve) Calcd for C13H18NO3 (M
+) 222.1256, found: 
222.1253. 
 
Step 2: (-)-5-(4-Methoxyphenyl)methoxy-2R,3S-epoxy-1-pentanol.  To a mixture of 
titanium tetra-isopropoxide (1.6 mL, 5.35 mmol), 4Ǻ molecular sieves (1.93 g) in dry 
DCM (100 mL) were added D-(-)-diisopropyltartrate (1.4 mL, 6.42 mmol) and anhydrous 
tert-butyl hydroperoxide (5.3 mL, 26.2 mmol, 5.0 M) under N2 at –40 
oC. After 10 min, a 
solution of 1 (2.37 g, 10.7 mmol) in dry DCM (10 mL) was added. The resulting yellow 
mixture was stirred at –20 oC for 18 h. After this time, 10% aqueous tartaric acid (50 mL) 
was added dropwise and the mixture was allowed to warm to RT over 1 h until the 
solution was transparent. Then the organic layer was separated, washed with brine and 
dried (MgSO4). The solvent was evaporated in vacuo and the residue was 
chromatographed on silica gel. Eluation with 30%-100% EtOAc/petrol afforded the title 
compound (2.41 g, 95%) as a yellow oil. []D24 -10.5 (c 2.3, CHCl3); 1H NMR  7.25 (d, 
2H, J 8.7 Hz, ArH), 6.89 (d, 2H, J 8.7 Hz, ArH), 4.47 (s, 2H, ArCH2), 3.86 (ddd, 1H, J 
12.0, 10.2, 5.1 Hz, H-1a), 3.80 (s, 3H, OMe), 3.68-3.54 (m, 2H, H-5), 3.46 (ddd, 1H, J 
12.3, 8.7, 3.6 Hz, H-1b), 3.17 (dt, 1H, J 9.0, 4.5 Hz, H-2), 3.10 (dd, 1H, J 10.5, 3.3 Hz, 
OH), 3.02 (dt, 1H, J 9.6, 4.2 Hz, H-3), 2.09 (ddd, 1H, J 14.7, 3.9, 2.7 Hz, H-4a), 1.74 
(dddd, 1H, J 14.4, 10.8, 9.3, 4.8 Hz, H-4b); 13C NMR  159.4 (ArC), 129.6 (ArCH), 
129.0 (ArC), 113.8 (ArCH), 73.1 (ArCH2), 66.3 (CH2-5), 59.8 (CH2-1), 55.2 ( CH-2), 
55.1 (OMe), 54.8 (CH-3), 27.9 (CH2-4); MS (CI +ve) m/z 238 (M
+); HRMS (CI +ve) 
Calcd for C13H18NO4 (M
+) 238.1205, found: 238.1197. 
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Mosher Ester Analysis: (-)-5-(4-Methoxyphenyl)methoxy-2S,3S-epoxy-1-pentyl-(R)-
α-methoxy-α(trifluoromethly)phenyl acetate. 5-(4-Methoxy)benzyloxy-2R,3S-epoxy-
1-pentanol (25 mg, 0.103 mmol) was dissolved in dry DCM (0.9 mL), then triethylamine 
(90 L), 4-dimethylaminopyridine (13 mg, 0.108 mmol) and R-(-)-α-methoxy-α-
(trifluoromethyl)phenylacetyl chloride (21 L, 0.113 mmol) were added. The mixture 
was stirred at RT for 15 min. All the volatiles were removed in vacuo to give a dark semi-
solid which was purified by column chromatography (15%-30% EtOAc/petrol) to give a 
pale yellow oil (42 mg, 90%, 82% ee). []D24 -31.0 (c 2.1, CHCl3); 1H NMR (major 
diastereomer)  7.55-7.51 (m, 2H, Ar*H), 7.43-7.39 (m, 3H, Ar*H), 7.25 (d, 2H, J 8.4 
Hz, ArH), 6.88 (d, 2H, J 8.7 Hz, ArH), 4.48 (dd, 1H, J 12.0, 3.9 Hz, H-1a), 4.44 (s, 2H, 
ArCH2), 4.36 (dd, 1H, J 12.0, 7.2 Hz, H-1b), 3.79 (s, 3H, MeOAr), 3.60-3.56 (m, 2H, H-
5), 3.57 (s, 3H, MeOC), 3.26-3.15 (m, 2H, H-2, H-3), 1.84 (apparent q, 2H, J 6.0 Hz, H-
4); 1H NMR (minor diastereomer, in part)  4.54 (dd, 1H, J 12.0, 3.9 Hz, H-1a), 4.31 (dd, 
1H, J 12.3, 7.2 Hz, H-1b);  13C NMR  166.4 (CO), 159.2 (ArC), 132.0 (Ar*C), 130.1 
(ArC), 129.7 (Ar*CH), 129.2 (ArCH), 128.4 (Ar*CH), 127.2 (Ar*CH), 123.1 (q, JC,F 
287.1 Hz, CF3), 113.7 (ArCH), 84.6 (q, JC,F 27.6 Hz, CCF3), 72.8 (ArCH2), 66.5 (CH2-5), 
64.77 (CH2-1), 55.5 (q, JC,F 1.5 Hz, COMe), 55.2 (MeOPh), 54.3 (CH-3), 53.0 (CH-2), 
28.7 (CH2-4); MS (CI +ve) m/z 453 (M-1
+); HRMS (CI +ve) Calcd for C23H25O6F3 (M
+) 
454.1603, found: 454.1596. 
 
Steps 4 and 5: 5-(4-Methoxyphenyl)methoxy-2S,3S-epoxypentanal and (-)-6-(4-
Methoxyphenyl)methoxy-3R,4S-epoxy-1-hexene (4). To a stirred solution oxalyl 
chloride (0.5 mL, 5.72 mmol) in dry DCM (7 mL) was added slowly dimethyl sulfoxide 
(0.68 mL, 9.53 mmol) at –50 oC to –60 oC under N2. The mixture was stirred for 5 min 
and 5-(4-methoxy)benzyloxy-2R,3S-epoxy-1-pentanol (907 mg, 3.81 mmol) in DCM (3 
mL) was added within 5 min via cannula. Stirring was continued for an additional 40 
min. Triethylamine (2.7 mL, 19.1 mmol) was then added and the mixture was stirred for 
5 min and then allowed to warm to RT.  After 20 min, the reaction was quenched by 
water (25 mL). The aqueous layer was re-extracted with additional DCM (3x). The 
combined organic portions were washed with saturated NaCl solution, HCl (1M), water, 
aqueous Na2CO3 (sat.), water and dried (MgSO4). The filtered solution was evaporated to 
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give a yellow oil. The crude aldehyde product was used in the next step without further 
purification. A solution of potassium bis(trimethylsilyl)amide (22.1 mL, 11.1 mmol, 0.5 
M in toluene) was cooled to –10 oC and transferred via cannula to a stirred suspension of 
methyltriphenylphosphonium bromide (4.09 g, 11.4 mmol) in dry THF (25 mL) at –10 oC 
under N2. The bright yellow suspension was stirred at RT for 20 min, re-cooled to –10 
oC 
and the above crude aldehyde in THF (8 mL) was added via cannula. TLC analysis (30% 
EtOAc/petrol) indicated complete disappearance of the crude 5-(4-methoxy)benzyloxy-
2S,3S-epoxypentanal after 2.5 h. The reaction mixture was poured into brine and 
extracted with diethyl ether (3x). The combined organic extract was dried (MgSO4). The 
solvent was evaporated under reduced pressure to give a semi-solid which was purified 
by column chromatography (10%-35% EtOAc/petrol) to give the title compound 5 as a 
pale yellow oil (685 mg, 77% overall for 2 steps). []D23 -14.2 (c 2.1, CHCl3); 1H NMR  
7.26 (dt, 2H, J 8.7, 2.7 Hz, ArH), 6.88 (dt, 2H, J 8.7, 3.0 Hz, ArH), 5.71 (ddd, 1H, J 17.4, 
10.5, 6.9 Hz, H-2), 5.47 (ddd, 1H, J 17.4, 1.8, 0.6 Hz, H-1a), 5.35 (ddd, 1H, J 10.8, 1.8, 
0.6 Hz, H-1b), 4.46 (s, 2H, ArCH2), 3.80 (s, 3H, OMe), 3.60 (td, 2H, J 6.3, 0.9 Hz, H-6), 
3.43 (dd, 1H, J 7.2, 4.5 Hz, H-3), 3.24 (ddd, 1H, J 6.9, 5.7, 4.5 Hz, H-4), 1.92-1.75 (m, 
2H, H-5); 13C NMR  159.1 (ArC), 132.3  (CH-2), 130.3 (ArC), 129.2 (ArCH), 120.5 
(CH2-1), 113.7 (ArCH), 72.7 (ArCH2), 67.0 (CH2-6), 56.9 (CH-3), 56.3 (CH-4), 55.2 
(OMe), 28.4 (CH2-5); MS (CI +ve) m/z 234 (M
+); HRMS (CI +ve) Calcd for C14H18NO3 
(M+) 234.1256, found: 234.1254. 
  
(+)-1-(4-Methoxyphenyl)methoxy-4S-[(1S-phenylmethoxymethyl)-2-
propenyl]amino-5-hepten-3S-ol (6) and its diastereomer (-)-1-(4-
Methoxyphenyl)methoxy-4R-[(1S-phenylmethoxymethyl)-2-propenyl]amino-5-
hepten-3R-ol (6'). To a mixture of 4 (860 mg, 3.68 mmol) and (2S)-1-
(phenylmethoxymethyl)but-3-enyl amine 5 (761 mg, 4.30 mmol) in dry acetonitrile (2 
mL), in a thick walled glass tube, was added lithium triflate (860 mg, 5.51 mmol). The 
vessel was flushed with nitrogen and sealed and then stirred and heated at 120 oC for 3 
days. The mixture was then cooled to RT and all volatiles were removed in vacuo to give 
a dark sticky oil which was purified by column chromatography (0%-10% 
methanol/DCM) and semi-preparative TLC (6% MeOH/DCM) to give compound 6 (943 
13 
mg, 62%) and the diastereomer 6' (262 mg, 17%) as yellow oils. Spectral data for 6: 
[]D24 +3.4 (c 3.2, CHCl3); 1H NMR  7.38-7.28 (m, 5H, Ar*H), 7.25 (d, 2H, J 8.7 Hz, 
ArH), 6.86 (d, 2H, J 8.7 Hz, ArH), 5.56-5.42 (m, 2H, H-5, H-2’), 5.21 (dd, 1H, J 10.5, 
2.1 Hz, x =CH2(Z)), 5.19 (dd, 1H, J 17.4, 2.1 Hz, =CH2(E)), 5.16 (dd, 1H, J 9.9, 2.1 Hz, 
=CH2(Z)), 5.10 (dd, 1H, J 17.4, 1.8 Hz, =CH2(E)), 4.53 (d, 1H, J 12.0 Hz, Ar*CHaCHb), 
4.48 (d, 1H, J 12.0 Hz, Ar*CHaCHb), 4.44 (s, 2H, ArCH2), 3.79 (s, 3H, OMe), 3.63 (dd, 
2H, J 6.6, 6.0 Hz, H-1), 3.50-3.35 (m, 4H, H-3, H-1’, CH2OBn), 2.88 (t, 1H, J 8.4 Hz, H-
4), 1.86 (dddd, 1H, J 14.1, 7.2, 6.9, 2.7 Hz, H-2a), 1.62 (dddd, 1H, J 14.4, 9.3, 6.3, 6.0 
Hz, H-2b); 13C NMR  159.0 (ArC), 137.9 (Ar*C), 137.4, 136.8 ( CH-5, CH-2’), 130.4 
(ArC), 129.2 (ArCH), 128.3, 127.6, 127.5 (3x Ar*CH), 118.3, 118.3 (CH2-6, CH2-3’), 
113.6 (ArCH), 73.2 (CH2OBn), 72.8 (Ar*CH2), 72.6 (ArCH2), 70.7 (CH-3), 67.5 (CH2-
1), 63.5 (CH-4), 57.3 (CH-1’), 55.1 (OMe), 33.4 (CH2-2); MS (CI +ve) m/z 412 (M+1
+, 
100%); HRMS (CI +ve) Calcd for C25H34NO4 (MH
+) 412.2488, found: 412.2505. 
Spectral data for 6': []D25 -5.6 (c 2.3, CHCl3); 1H NMR  7.34-7.27 (m, 5H, Ar*H), 7.24 
(d, 2H, J 8.7 Hz, ArH), 6.86 (d, 2H, J 8.4 Hz, ArH), 5.80 (ddd, 1H, J 17.4, 10.2, 6.6 Hz, 
H-2’), 5.61 (ddd, 1H, J 17.1, 10.5, 8.1 Hz, H-5), 5.22-5.08 (m, 4H, H-6, H-3’), 4.52 (s, 
2H, ArCH2 or Ar*CH2), 4.43 (s, 2H, ArCH2 or Ar*CH2), 3.79 (s, 3H, OMe), 3.67-3.60 
(m, 2H,, H-1), 3.56-3.36 (m, 4H, H-2, H-1’, CH2OBn), 2.99 (t, 1H, J 8.1 Hz, H-4), 1.86 
(dtd, 1H, J 14.1, 6.3, 2.7 Hz, H-2a), 1.63 (ddt, 1H, J 14.1, 9.3, 6.3 Hz, H-2b); 13C NMR  
159.1 (ArC), 138.8 (CH-2’), 138.2 (Ar*C), 137.9 (CH-5), 130.3 (ArC), 129.2 (ArCH), 
128.3, 127.6, 127.5 (3x Ar*CH), 117.8 (CH2-6), 116.1 (CH2-3’), 113.7 (ArCH), 73.1, 
72.7 (Ar*CH2 and ArCH2), 72.9 (CH2OBn), 71.6 (CH-3), 67.9 (CH2-1), 65.0 (CH-4), 
58.4 (CH-1’), 55.2 (OMe), 33.3 (CH2-2); MS (CI +ve) m/z 412 (M+1
+, 100%); HRMS 
(CI +ve) Calcd for C25H34NO4 (MH
+) 412.2488, found: 412.2474.  
 
 (+)-4S-Ethenyl-5S-[2-(4-methoxyphenyl)methoxy]ethyl-3-(1S-
phenylmethoxymethyl-2-propenyl)-1,3-oxazolidin-2-one (7). A solution of 6 (226 mg, 
0.549 mmol) in dry DCM (15 mL) was cooled to 0 0C and triethylamine (311 mg, 0.43 
mL, 3.075 mmol) was added. A solution of triphosgene (82 mg, 0.275 mmol) in dry 
DCM (1 mL) was cooled to 0 oC and was then added to the above amine solution at 0 oC. 
TLC analysis (34% EtOAc/petrol) indicated complete disappearance of the compound 6 
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after 2.5 h. The reaction was quenched with water (30 mL). The aqueous portion was 
extracted with DCM (4x). The combined organic portions were dried (MgSO4) and 
filtered and the solvent was evaporated to give a yellow semi-solid. Chromatography of 
the residue eluting with (15%-40%) EtOAc/petrol gave diastereomerically pure 
compound 7 (226 mg, 94%) as a pale yellow oil. []D28 +29.1 (c 3.6, CHCl3); 1H NMR 
(500 MHz)  7.35-7.26 (m, 5H, Ar*H), 7.22 (d, 2H, J 8.5 Hz, ArH), 6.86 (d, 2H, J 8.5 
Hz, ArH), 5.81 (ddd, 1H, J 17.5, 10.5, 7.5 Hz, H-2’), 5.69 (ddd, 1H, J 17.0, 10.0, 9.0 Hz, 
H-1’’), 5.22 (dt, 1H, J 17.5, 1.0 Hz, H-3’a (E)), 5.19 (dt, 1H, J 10.5, 1.0 Hz, H-2’’a), 5.18 
(dt, 1H, J 10.5, 1.0 Hz, H-3’b), 5.11 (dt, 1H, J 17.0, 1.0 Hz, H-2’’b), 4.59 (d, 1H, J 12.0 
Hz, Ar*CHaCHb), 4.44 (d, 1H, J 12.0 Hz, Ar*CHaCHb), 4.40 (d, 1H, J 11.0 Hz, 
ArCHaCHb), 4.36 (d, 1H, J 11.5 Hz, ArCHaCHb), 4.36-4.32 (m, 1H, H-1’), 4.24 (td, 1H, J 
7.5, 4.5 Hz, H-5), 3.90 (dd, 1H, J 9.0 7.5 Hz, H-4), 3.81 (dd, 1H, J 10.5, 9.5 Hz, 
CHaCHbOBn), 3.77 (s, 3H, OMe), 3.61 (dd, 1H, J 10.0, 5.5 Hz, CHaCHbOBn), 3.57-3.54 
(m, 2H, CH2CH2O), 1.95-1.84 (m, 2H, CH2CH2O); 
13C NMR  159.0 (ArC), 157.3 (CO), 
137.6 (Ar*C), 135.9 (CH-2’), 133.3 (CH-1’’), 123.0 (ArC), 129.2 (ArCH), 128.2, 127.8, 
127.6 (3x Ar*CH), 120.3 (CH2-2’’), 118.4 (CH2-3’), 113.6 (ArCH), 76.2 (CH-5), 72.7 
(Ar*CH2 and ArCH2), 68.3 (CH2OBn), 65.2 (CH2CH2O), 64.3 (CH-4), 56.0 (CH-1’), 
55.1 (OMe), 33.4 (CH2CH2O); MS (CI +ve) m/z 438 (M+1
+); HRMS (CI +ve) Calcd for 
C26H32NO5 (MH
+) 438.2280, found: 438.2262.  
 
 (+)-4R-Ethenyl-5R-[2-(4-methoxyphenyl)methoxy]ethyl-3-(1S-
phenylmethoxymethyl-2-propenyl)-1,3-oxazolidin-2-one (7') 
 
The same procedure described above for the preparation of 7 
was used starting with 6' (49 mg, 0.118 mmol) in dry DCM 
(5 mL), triethylamine (92 l, 0.66 mmol) and triphosgene 
(18 mg, 0.059 mmol) in dry DCM (1 mL). Compound 7' (36 
mg, 69%) was obtained as a pale yellow oil. []D27 +12.7 (c 1.8, CHCl3); 1H NMR  
7.36-7.29 (m, 5H, Ar*H), 7.23 (d, 2H, J 8.7 Hz, ArH), 6.87 (d, 2H, J 8.7 Hz, ArH), 5.95 
(ddd, 1H, J 17.7, 9.9, 6.6 Hz, H-2’), 5.69 (ddd, 1H, J 17.4, 9.6, 8.7 Hz, H-1’’), 5.29-5.20 
(m, 4H, H-3’, H-2’’), 4.54 (d, 1H, J 12.6 Hz, Ar*CHaCHb), 4.50 (d, 1H, J 12.3 Hz, 
N
O
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Ar*CHaCHb), 4.42 (d, 1H, J 11.4 Hz, ArCHaCHb), 4.37 (d, 1H, J 11.1 Hz, ArCHaCHb), 
4.27 (ddd, 1H, J 7.8, 7.5, 4.8 Hz, H-5), 4.25-4.17 (m, 1H, H-1’), 3.98 (dd, 1H, J 8.7, 7.5 
Hz, H-4), 3.91 (t, 1H, J 9.0 Hz, CHaCHbOBn), 3.80 (s, 3H, OMe), 3.59-3.53 (m, 3H, 
CHaCHbOBn, CH2CH2O), 1.98-1.81 (m, 2H, CH2CH2O); 
13C NMR (one Ar*CH could 
not be observed)  159.2 (ArC), 156.9 (CO), 137.9 (Ar*C), 135.7 (CH-1’’), 132.6 (CH-
2’), 130.1 (ArC), 129.3 (ArCH), 128.3, 127.6 (2x Ar*CH), 120.5 (CH2-2’’), 118.8 (CH2-
3’), 113.7 (ArCH), 76.5 (CH-5), 73.0 (Ar*CH2), 72.8 (ArCH2), 69.8 (CH2OBn), 66.2 
(CH-4), 65.3 (CH2CH2O), 56.1 (CH-1’), 55.2 (OMe), 33.8 (CH2CH2O); MS (CI +ve) m/z 
438 (M+1+); HRMS (EI +ve) Calcd for C26H31NO5 (M
+) 437.2202, found: 437.2202.  
 
 
(-)-(1S,5S,7aS)–1-[2-(4-Methoxyphenyl)methoxy]ethyl-5-(phenylmethoxy)methyl-
5,7a-dihydro-1H,3H-pyrrolo[1,2-c]oxazol-3-one (8). Grubbs’ Catalyst I (212 mg, 0.258 
mmol) was added to a solution of 7 (520 mg, 1.19 mmol) in dry DCM (200 mL) under 
nitrogen. The mixture was heated at reflux under nitrogen for 25 h. TLC analysis (35% 
EtOAc/petrol) indicated incomplete conversion of compound 7. Additional Grubbs’ 
Catalyst I (85.0 mg, 0.103 mmol) was added and the reaction was continued under the 
same conditions for another 17 h. The reaction mixture was cooled and then the solvent 
was removed in vacuo to give a brown oil which was purified by column chromatography 
(25%-85% EtOAc/petrol) to give 8 (204 mg, 97%) as a light brown oil. []D26 -134.9 (c 
2.1, CHCl3); 
1H NMR (500 MHz)  7.34-7.26 (m, 5H, Ar*H), 7.23 (d, 2H, J 8.5 Hz, 
ArH), 6.87 (d, 2H, J 8.5 Hz, ArH), 5.96 (dt, 1H, J 5.5, 2.0 Hz, H-7), 5.87 (bd, 1H, J 6.0 
Hz, H-6), 4.74-4.72 (m, 1H, H-5), 4.56 (d, 1H, J 12.0 Hz, Ar*CHaCHb), 4.53 (d, 1H, J 
12.0 Hz, Ar*CHaCHb), 4.54-4.52 (m, 1H, H-1), 4.44 (d, 1H, J 11.5 Hz, ArCHaCHb), 
4.44-4.43 (m, 1H, H-7a), 4.40 (d, 1H, J 11.5 Hz, ArCHaCHb), 3.77 (s, 3H, OMe), 3.61 
(apparent dd, 2H, J 7.0, 5.0 Hz, CH2CH2O), 3.53 (dd, 1H, J 10.0, 5.0 Hz, CHaCHbOBn), 
3.50 (dd, 1H, J 10.0, 5.5 Hz, CHaCHbOBn), 2.14-2.02 (m, 2H, CH2CH2O); 
13C NMR one 
ArC could not be observed  161.7 (CO), 158.8 (ArC), 137.5 (Ar*C), 131.4 (CH-7), 
129.5 (CH-6), 128.9 (ArCH), 127.9, 127.2, 127.1 (3x Ar*CH), 113.3 (ArCH), 79.4 (CH-
1), 72.8 (Ar*CH2), 72.5 (ArCH2), 70.9 (CH2OBn), 70.0 (CH-7a), 66.0 (CH-5), 65.2 
16 
(CH2CH2O), 54.8 (OMe), 35.1 (CH2CH2O); MS (CI +ve) m/z 410 (M+1
+); HRMS (CI 
+ve) Calcd for C24H28NO5 (M
+) 410.1967, found: 410.1929. 
 
 
(-)-(1S,5S,6R,7S,7aS)–1-[2-(4-Methoxyphenyl)methoxy]ethyl-5-
(phenylmethoxy)methyl-5,6,7,7a-tetrahydro-6,7-dihydroxy-1H,3H-pyrrolo[1,2-
c]oxazol-3-one (9).  To a solution of 8 (170 mg, 0.416 mmol) in acetone (3 mL) were 
added water (2 mL), 4-morpholine N-oxide (107 mg, 0.916 mmol) and potassium osmate 
dihydrate (15 mg, 0.042 mmol). The mixture was stirred at RT for 21 h. Then all volatiles 
were removed in vacuo. The residue was dissolved in toluene and evaporated to dryness 
in vacuo to give a dark, semi-solid which was chromatographed on silica gel (eluting with 
0%-7.5% methanol/DCM) to afford compound 9 as a brown oil (156 mg, 85%). []D24 -
84.0 (c 1.3, CHCl3); 
1H NMR (500 MHz)  7.26-7.17 (m, 5H, Ar*H), 7.14 (d, 2H, J 8.0 
Hz, ArH), 6.78 ( d, 2H, J 9.0 Hz, ArH), 4.79 (ddd, 1H, J 7.5, 5.5, 2.5 Hz, H-1), 4.48 (d, 
1H, J 12.0 Hz, Ar*CHaCHb), 4.45 (d, 1H, J 12.0 Hz, Ar*CHaCHb), 4.34 (d, 1H, J 11.5 
Hz, ArCHaCHb), 4.30 (d, 1H, J 11.5 Hz, ArCHaCHb), 4.26 (dd, 1H, J 5.0, 4.0 Hz, H-6), 
3.82 (bs, 1H, H-7), 3.70 (s, 3H, OMe), 3.64-3.62 (m, 2H, H-5, CHaCHbOBn), 3.57-3.54 
(m, 2H, H-7a, CHaCHbOBn), 3.52-3.49 (m, 2H, CH2CH2O), 1.99-1.92 (m, 1H, 
CHaCHbCH2O), 1.91-1.84 (m, 1H, CHaCHbCH2O); 
13C NMR  161.8 (CO), 159.2 (ArC), 
137.8 (Ar*C), 129.9 (ArC), 129.4 (ArCH), 128.4, 127.8, 127.6 (3x Ar*CH), 113.8 
(ArCH), 76.9 (CH-6), 73.5 (Ar*CH2), 73.1 (CH-1), 73.0 (ArCH2), 71.5 (CH-7), 70.2 
(CH2OBn), 66.6 (CH-7a), 65.7 (CH2CH2O), 62.0 (CH-5), 55.3 (OMe), 35.3 (CH2CH2O); 
MS (CI +ve) m/z 444 (M+1+); HRMS (EI +ve) Calcd for C24H29NO7 (M
+) 443.1944, 
found: 443.1943.  
 
 (-)-(1S,5R,6R,7S,7aS)–6,7-Diacetoxy-1-[2-(4-methoxyphenyl)methoxy]ethyl-5-
(phenylmethoxy)methyl-5,6,7,7a-tetrahydro-1H,3H-pyrrolo[1,2-c]oxazol-3-one (10). 
Compound 9 (174 mg, 0.394 mmol) was dissolved in anhydrous pyridine (2.0 mL) and 
then Ac2O (2.0 mL) was added. The mixture was stirred at RT for 23 h, then diluted with 
DCM (30 mL) and washed with saturated aqueous NaHCO3 solution at 0 
oC. The 
aqueous portion was extracted with DCM (4x). The combined organic portions were 
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dried (MgSO4), filtered and evaporated in vacuo to give an oil which was purified by 
column chromatography (30%-50% EtOAc/petrol) to give product 10 as a pale yellow oil 
(174 mg, 84%). []D26 -13.9 (c 2.3, CHCl3); 1H NMR  7.33-7.27 (m, 5H, Ar*H), 7.21 
(d, 2H, J 8.7 Hz, ArH), 6.87 (d, 2H, J 8.4 Hz, ArH), 5.56 (dd, 1H, J 6.6, 3.6 Hz, H-6), 
5.37 (t, 1H, J 3.6 Hz, H-7), 4.60 (ddd, 1H, J 7.5, 6.0, 3.9 Hz, H-1), 4.58 (d, 1H, J 11.7 
Hz, Ar*CHaCHb), 4.52 (d, 1H, J 12.0 Hz, Ar*CHaCHb), 4.43 (d, 1H, J 11.4 Hz, 
ArCHaCHb), 4.38 (d, 1H, J 11.7 Hz, ArCHaCHb), 3.96-3.91 (m, 2H, H-5, H-7a), 3.79 (s, 
3H, OMe), 3.70 (dd, 1H, J 10.2, 3.6 Hz, CHaCHbOBn), 3.63 (dd, 1H, J 10.2, 3.0 Hz, 
CHaCHbOBn), 3.56 (dd, 2H, J 6.6, 5.4 Hz, OCH2CH2), 2.15-1.94 (m, 2H, OCH2CH2), 
2.10 (s, 3H, Ac), 1.99 (s, 3H, Ac); 13C NMR  169.8 (CO, Ac), 169.6 (CO, Ac), 160.7 
(CO-3), 159.2 (ArC), 137.6 (Ar*C), 129.8 (ArC), 129.2 (ArCH), 128.3, 127.6, 127.4 (3x 
Ar*CH), 113.7 (ArCH), 74.3 (CH-6), 73.3 (Ar*CH2), 72.9 (CH-1), 72.8 (ArCH2), 72.1 
(CH-7), 68.9 (CH2OBn), 65.1 (OCH2CH2), 64.7 (CH-7a), 59.9 (CH-5), 55.1 (OMe), 35.0 
(OCH2CH2), 20.5 (CH3, Ac), 20.3 (CH3, Ac); MS (CI +ve) m/z 528 (M+1
+); HRMS (CI 
+ve) Calcd for C28H34NO9 (MH
+) 528.2234, found: 528.2257.  
 
 (-)-(1S,5R,6R,7S,7aS)–6,7-Diacetoxy-1-(2-hydroxy)ethyl-5-(phenylmethoxy) methyl-
5,6,7,7a-tetrahydro-1H,3H-pyrrolo[1,2-c]oxazol-3-one (11). To a solution of 10 (227 
mg, 0.432 mmol) in dichloromethane (30 mL) and water (2.5 mL) was added 2,3-
dichloro-5,6-dicyanobenzoquinone (DDQ) (137 mg, 0.604 mmol). After the mixture was 
stirred at RT for 2.5 h, TLC analysis (70% EtOAc/petrol) indicated the presence of 
compound 10. Additional DDQ (59 mg, 0.259 mmol) was then added to the mixture. The 
reaction was continued for another 3 h. The mixture was diluted with water (25 mL) and 
extracted with DCM (4x). The combined organics were dried (MgSO4) and filtered and 
the solvent was removed under reduced pressure to give a red, semi-solid that was 
purified by column chromatography (40%-90% EtOAc/petrol) to give the product 11 as a 
pale yellow oil (114 mg, 65%). []D25 -4.6 (c 2.0, CHCl3); 1H NMR  7.36-7.24 (m, 5H, 
Ar*H), 5.56 (dd, 1H, J 6.6, 3.6 Hz, H-6), 5.41 (t, 1H, J 3.6 Hz, H-7), 4.62 (ddd, 1H, J 7.8, 
5.7, 3.6 Hz, H-1), 4.58 (d, 1H, J 12.0 Hz, Ar*CHaCHb), 4.52 (d, 1H, J 12.3 Hz, 
Ar*CHaCHb), 3.96-3.91 (m, 2H, H-7a, H-5), 3.78 (bt, 2H, J 5.7 Hz, CH2CH2OH), 3.71 
(dd, 1H, J 10.2, 3.6 Hz, CHaCHbOBn), 3.62 (dd, 1H, J 10.2, 3.0 Hz, CHaCHbOBn), 2.22 
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(bs, 1H, OH), 2.13-1.85 (m, 2H, CH2CH2OH), 2.11 (s, 3H, Ac), 1.99 (s, 3H, Ac); 
13C 
NMR  170. 1, 169.8 (2x CO, Ac), 160.7 (CO-3), 137.6 (Ar*C), 128.4, 127.7, 127.5 (3x 
Ar*CH), 74.3 (CH-6), 73.4 (Ar*CH2), 73.0 (CH-1), 72.2 (CH-7), 68.9 (CH2OBn), 64.9 
(CH-7a), 59.9 (CH-5), 58.2 (CH2CH2OH), 37.3 (CH2CH2OH), 20.6, 20.4 (2x CH3, Ac); 
MS (CI +ve) m/z 408 (M+1+, 100%); HRMS (CI +ve) Calcd for C20H26NO8 (MH
+) 
408.1658, found: 408.1666. 
 
Four Step Synthesis of (-)-(1S,2R,3R,7S,7aR)–1,2,7-Triacetoxy-3-
(acetoxymethyl)hexahydro-1H-pyrrolizine (15) from 13. 
(+)-(2S,3R,4S,5R)-5-[(1S)-1,3-Dihydroxypropyl]-2-[(phenylmethoxy)methyl] 
pyrrolizine-3,4-diol (13). To a solution of 12 (174 mg, 0.429 mmol) in ethanol (6 mL) 
was added sodium hydroxide (171 mg, 4.285 mmol). The reaction was heated at 70 oC in 
a sealed tube for 37 h. The volatiles were then removed in vacuo to give a yellow solid, 
and the residue was treated with 1M hydrochloric acid (6 mL). The volatiles were 
removed in vacuo to give a yellow solid that was purified by acidic ion-exchange 
chromatography to give the desired compound 12 (ca 168 mg) as a yellow solid. This 
compound appeared pure by NMR analysis but from the mass recovery (>100%) this 
material was believed to contain salts. Spectral data for 12: 1H NMR (CD3OD)  7.42-
7.26 (m, 5H, Ar*H), 4.66 (d, 1H, J 11.7Hz, Ar*CHaCHb), 4.60 (d, 1H, J 11.7 Hz, 
Ar*CHaCHb), 4.24 (dd, 1H, J 8.7, 3.9 Hz, H-3), 4.22-4.16 (m, 2H, H-4, CHOH), 3.86 
(dd, 1H, J 10.5, 3.3 Hz, CHaCHbOBn), 3.82-3.76 (m, 3H, CHaCHbOBn, CH2CH2OH), 
3.69 (ddd, 1H, J 8.7, 6.0, 3.0 Hz, H-2), 3.53 (dd, 1H, J 9.0, 3.0 Hz, H-5), 1.92 (dtd, 1H, J 
14.1, 7.2, 3.0 Hz, CHaCHbCH2OH), 1.67 (ddt, 1H, J 14.4, 9.0, 5.7 Hz, CHaCHbCH2OH); 
13C NMR (CD3OD)  138.9 (Ar*C), 129.4, 129.0, 128.9 (3x Ar*CH), 74.3 (Ar*CH2), 
73.5 (CH-3), 71.6 (CH-4), 67.9 (CH2OBn), 67.6 (CH-5), 66.8 (CHOH), 61.7 (CH-2), 
59.1 (CH2CH2OH), 37.5 (CH2CH2OH); MS (CI +ve) m/z 298 (M+1
+, 100%); HRMS (CI 
+ve) Calcd for C15H24NO5 (MH
+) 298.1654, found: 298.1658.  
 
 
(-)-(1S,2R,3R,7S,7aR)–1,2,7-Triacetoxy-3-(acetoxymethyl)hexahydro-1H-pyrrolizine 
(15). To a stirred mixture of 12 obtained above, triphenylphosphine (157 mg, 0.600 
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mmol) and anhydrous pyridine (5 mL) at 0 0C was added dropwise diisopropyl 
azodicarboxylate (0.12 mL, 0.60 mmol) under nitrogen. The mixture was stirred at 0 oC 
for 4 h and then warm up to RT for 3 h. The volatiles were removed in vacuo then 1M 
hydrochloric acid (15 mL) and DCM (15 mL) were added. The aqueous layer was 
washed with DCM (15 mL) and then concentrated in vacuo to give a yellow solid, which 
was purified by acidic ion-exchange chromatography to give 13. This material was 
dissolved in methanol (2 mL) and palladium chloride (21 mg, 0.118 mmol) was added. 
The mixture was stirred under one atmosphere of hydrogen (H2 balloon) at RT for 1.5 h. 
The mixture was then filtered through a plug of cotton wool and the solvent was removed 
under reduced pressure to give 14 as a pale yellow oil. This oil was then dissolved in 
anhydrous pyridine (1mL) and Ac2O (1 mL) was added to the solution. The mixture was 
stirred at RT for 22 h, then diluted with DCM (20 mL) and washed with saturated 
NaHCO3 solution at 0
0C. The aqueous portion was extracted with DCM (3x). The 
combined organic portions were dried (MgSO4), filtered and evaporated in vacuo to give 
a solid which was purified by column chromatography (35%-90% EtOAc/petrol) to give 
15 as a pale yellow oil (21 mg, 23% overall for 4 steps). []D26 -19.0 (c 2.1, CHCl3); 1H 
NMR  5.44 (t, 1H, J 3.9 Hz, H-1), 5.31 (dd, 1H, J 15.3, 7.8 Hz, H-7), 5.10 (dd, 1H, J 
9.3, 4.2 Hz, H-2), 4.20 (dd, 1H, J 11.4, 4.2 Hz, CHaCHbOAc), 4.04 (dd, 1H, J 11.4, 5.4 
Hz, CHaCHbOAc), 3.87 (dd, 1H, J 7.5, 3.9 Hz, H-7a), 3.32 (ddd, 1H, J 9.6, 5.7, 4.2 Hz, 
H-3), 3.18 (dt, 1H, J 11.1, 7.8 Hz, H-5a), 2.95 (ddd, 1H, J 11.1, 7.2, 5.4 Hz, H-5b), 2.14-
1.92 (m, 2H, H-6), 2.11 (s. 3H, Ac), 2.09 (s, 3H, Ac), 2.03 (s, 3H, Ac), 2.01 (s, 3H, Ac); 
13C NMR  170.8, 170.4, 169.6, 169.4 (4x CO), 74.4 (CH-7), 73.7 (CH-2), 71.7 (CH-1), 
66.7 (CH-3), 65.0 (CH2OAc), 64.7 (CH-7a), 52.3 (CH2-5), 30.9 (CH2-6), 21.0, 20.8, 20.7, 
20.4 (4x CH3, Ac); MS (CI +ve) m/z 358 (M+1
+, 100%); HRMS (CI +ve) Calcd for 
C16H24NO8 (MH
+) 358.1502, found: 358.1485. 
 
 
(+)-(1S,2R,3R,7S,7aR)–Hexahydro–3-hydroxymethyl–1H-pyrrolizine-1,2,7-triol, 
[(+)-1-Epiaustraline] (1). To a solution of 15 (21 mg, 0.109 mmol) in methanol (2 mL) 
was added Amberlyst A-26 resin (50 mg). The reaction mixture was stirred for 2 h at RT. 
The TLC analysis indicated the complete conversion. The mixture was then filtered 
20 
through a sintered glass frit and rinsed with methanol. The filtrate was concentrated to 
give the title compound (11 mg) as a colorless oil. []D25 +14.3 (c 1.1, H2O) [lit.10a []D25 
+13.695 (c 1.72, H2O)]; The 
1H and 13C NMR spectral data for this compound were 
essentially identical to that reported in the literature.10 1H NMR (500 MHz, D2O)  4.57 
(dt, 1H, J 5.0, 4.5 Hz, H-7), 4.40 (t, 1H, J 5.0 Hz, H-1), 3.91 (dd, 1H, J 9.0, 4.5 Hz, H-2), 
3.80 (dd, 1H, J 11.5, 4.0 Hz, CHaCHbOH), 3.63 (dd, 1H, J 11.5, 7.0 Hz, CHaCHbOH), 
3.46 (t, 1H, J 5.0 Hz, H-7a), 3.17 (ddd, 1H, J 10.5, 7.0, 4.0 Hz, H-5a), 3.02 (ddd, 1H, J 
9.0, 6.5, 4.0 Hz, H-3), 2.93 (ddd, 1H, J 10.5, 9.5, 6.5 Hz, H-5b), 2.04 (ddt, 1H, J 13.5, 
6.5, 4.0 Hz, H-6a), 1.96 (dddd, 1H, J 13.5, 9.5, 7.0, 5.0 Hz, H-6b); 13C NMR (D2O)  
75.2 (CH-2), 73.7 (CH-7), 72.7 (CH-1), 70.6 (CH-3), 66.6 (CH-7a), 63.6 (CH2OH), 52.7 
(CH2-5), 35.9 (CH2-6); MS (CI +ve) m/z 190 (M+1
+, 100%); HRMS (EI +ve) Calcd for 
C8H15NO4 (M
+) 189.1001, found: 189.0995. 
 
 
(-)-(3aS,3bR,4S,8R,8aR)-4-[2-(4-Methoxyphenyl)methoxy]ethyl-8-
phenylmethoxylmethyltetrahydro-3aH-[1,3,2]dioxathiolo[4’,5’:3,4]pyrrolo[1,2-
c][1,3]oxazol-6-one 2,2-dioxide (16). To a solution of 9 (190 mg, 0.430 mmol) in DCM 
(5 mL) was added Et3N (0.14 mL, 0.988 mmol) followed by thionyl chloride (39.2 L, 
0.537 mmol) at 0 oC. The mixture was stirred for 30 min at 0 oC and water (15 mL) was 
added to the mixture. The aqueous layer was extracted with DCM (4x). The combined 
organic phases were dried (MgSO4), filtered and evaporated under reduced pressure to 
give a brown oil. The crude cyclic sulfite was used in the next step without further 
purification.  The crude cyclic sulfite obtained above was dissolved in 7 mL of a solution 
of CCl4: CH3CN: H2O (2: 2: 3, v/v/v) and RuCl3.3H2O (6 mg, 0.024 mmol) was added 
followed by NaIO4 (175 mg, 0.816 mmol). The mixture was stirred at RT for 2.5 h and 
then diluted with diethyl ether (20 mL) and water (20 ml). The organic layer was washed 
with saturated aqueous sodium bicarbonate solution followed by brine and then dried 
(MgSO4). The solvent was evaporated and then purification of the residue by column 
chromatography (35%-50% EtOAc/petrol) gave compound 16 (191 mg, 88%) as a pale 
yellow oil. []D24 –52.9 (c 2.0, CHCl3); 1H NMR  7.37-7.34 (m, 5H, Ar*H), 7.22-7.19 
(m, 2H, Ar*H), 7.20 (d, 2H, J 8.7 Hz, ArH), 6.86 (d, 2H, J 8.7 Hz, ArH), 5.35 (dd, 1H, J 
21 
5.4, 0.9 Hz, H-8a), 5.04 (t, 1H, J 5.4 Hz, H-3a), 4.78 (td, 1H, J 6.6, 3.9 Hz, H-4), 4.49 (d, 
1H, J 12.0 Hz, ArCHaCHb or Ar*CHaCHb), 4.43-4.39 (m, 2H, ArCHaCHb or Ar*CHaCHb 
and H-8), 4.39 (s, 2H, ArCH2 or Ar*CH2), 4.25 (dd, 1H, J 4.8, 3.9 Hz, H-3b), 3.78 (s, 3H, 
OMe), 3.73-3.57 (m, 4H, CH2OBn and CH2CH2O), 2.14-2.07 (m, 2H, CH2CH2O); 
13C 
NMR  159.3 (ArC), 158. 7 (CO-6), 136.6 (Ar*C), 129.7 (ArC), 129.4, 128.7, 128.3, 
127.7 (3x Ar*CH and 1x ArCH), 113.8 (ArCH), 87.6 (CH-8a), 84.4 (CH-3a), 73.8 
(ArCH2 or Ar*CH2), 73.7 (CH-4), 73.1 (Ar*CH2 or ArCH2), 70.9 (CH2OBn), 67.1 (CH-
3b), 65.7 (CH2CH2O), 62.3 (CH-8), 55.2 (OMe), 34.9 (CH2CH2O); MS (CI +ve) m/z 506 
(M+1+); HRMS (EI +ve) Calcd for C24H27NO9S (M
+) 505.1407, found: 505.1426.  
 
(-)-(1S,5S,6R,7R,7aS)-6-Hydroxyl-1-[2-(4-methoxyphenyl)methoxy]ethyl-7-
phenylcarbonyloxy-5-phenylmethoxymethyltetrahydro-1H-pyrrolo[1,2-c][1, 
3]oxazol-3-one (17). To a solution of 16 (192 mg, 0.381 mmol) in DMF (8 mL) was 
added benzoic acid (79 mg, 0.65 mmol) followed by cesium carbonate (186 mg, 0.572 
mmol). The mixture was stirred under nitrogen at 40 oC for 3 h. DMF was removed under 
reduced pressure and the residue was suspended in THF (8 mL). Water (20 drops) 
followed by concentrated sulfuric acid (4 drops) was added and the suspension became a 
clear solution. The solution was stirred at RT for 9.5 h. The volatiles were removed in 
vacuo to give a semi-solid which was purified by column chromatography (20%-60% 
EtOAc/petrol) to give 18 (184 mg, 88%) as a mixture (73:27) of regioisomers as a 
colourless oil. Spectral data for the major isomer: 1H NMR  7.96 (d, 2H, J 7.8 Hz, BzH), 
7.60 (td, 1H, J 7.5, 0.6 Hz, BzH), 7.43 (t, 2H, J 7.8 Hz, BzH), 7.32-7.26 (m, 5H, Ar*H), 
7.18 (d, 2H, J 8.4 Hz, ArH), 6.81 (d, 2H, J 7.8 Hz, ArH), 5.01 (dd, 1H, J 6.3, 4.2 Hz, H-
7), 4.97 (dt, 1H, J 7.2, 5.1 Hz, H-1), 4.61 (t, 1H, J 3.6 Hz, H-6), 4.58 (s, 2H, Ar*CH2), 
4.36 (s, 2H, ArCH2), 4.10 (bdd, 1H, J 9.0, 5.1 Hz, H-5), 3.88 (dd, 1H, J 6.3, 5.1 Hz, H-
7a), 3.76 (s, 3H, OMe), 3.75-3.58 (m, 4H, CH2OBn, CH2CH2O), 2.11-2.00 (m, 2H, 
CH2CH2O); 
13C NMR  166.6 (CO, Bz), 160.6 (CO-3), 159.0 (ArC), 137.7 (Ar*C), 133.6 
(CH, Bz), 123.0 (ArC), 129.7, 129.2, 128.5, 128.4, 127.7, 127.5 (1x ArCH, 3x Ar*CH 
and 2x BzCH), 128.7 (C, Bz), 113.7 (ArCH), 84.3 (CH-7), 79.0 (CH-6), 78.3 (CH-1), 
73.3 (Ar*CH2), 72.7 (ArCH2), 69.6 (CH2OBn), 67.7 (CH-7a), 65.4 (CH2CH2O), 64.4 
(CH-5), 55.2 (OMe), 35.2 (CH2CH2O), 20.8 (CH3, Ac); MS (ES +ve) m/z 548 (M+1
+, 
22 
25%), 570 (M+Na+, 100%); HRMS (ES +ve) Calcd for C31H34NO8 (MH
+) 548.2284, 
found: 548.2284.  
 
(-)-(1S,5R,6R,7R,7aS)-6-Acetoxy-1-[2-(4-methoxyphenyl)methoxy]ethyl-7-
phenylcarbonyloxy-5-phenylmethoxymethyltetrahydro-1H-pyrrolo[1,2-c][1, 
3]oxazol-3-one (18) and (1S,5R,6S,7S,7aS)-7-Acetoxy-1-[2-(4-
methoxyphenyl)methoxy]ethyl-6-phenylcarbonyloxy-5-
phenylmethoxymethyltetrahydro-1H-pyrrolo[1,2-c][1, 3]oxazol-3-one (18') 
 
The same procedure described 
above for the preparation of 10 
was used starting with 17 (224 
mg, 0.409 mmol), Ac2O (2.0 
mL) in anhydrous pyridine (2 
mL). Compounds 18 (160 mg, 66%) and its regioisomer 18' (61 mg, 25%) were obtained 
respectively, as  pale yellow oils. Spectral data for 18: []D23 -30.1 (c 1.1, CHCl3); 1H 
NMR  7.94 (dt, 2H, J 8.4, 1.2 Hz, BzH), 7.60 (tt, 1H, J 7.8, 1.2 Hz, BzH), 7.43 (t, 2H, J 
8.1 Hz, BzH), 7.33-7.28 (m, 2H, Ar*H), 7.26-7.23 (m, 3H, Ar*H), 7.18 (d, 2H, J 9.0 Hz, 
ArH), 6.81 (d, 2H, J 9.0 Hz, ArH), 5.60 (t, 1H, J 3.6 Hz, H-6), 5.15 (dd, 1H, J 6.0, 3.3 
Hz, H-7), 5.06 (ddd, 1H, J 7.8, 4.8, 3.9 Hz, H-1), 4.59 (s, 2H, Ar*CH2), 4.36 (s, 2H, 
ArCH2), 4.15 (dd, 1H, J 6.6, 3.9 Hz, H-5), 3.93 (dd, 1H, J 6.3, 4.2 Hz, H-7a), 3.86 (dd, 
1H, J 9.6, 3.6 Hz, CHaCHbOBn), 3.78 (s, 3H, OMe), 3.72 (dd, 1H, J 9.6, 4.2 Hz, 
CHaCHbOBn), 3.64-3.57 (m, 2H, CH2CH2O), 2.19-1.98 (m, 2H, CH2CH2O), 2.09 (s, 3H, 
Ac); 13C NMR  170.3 (CO, Ac), 166.0 (CO, Bz), 160.0 (CO-3), 159.1 (ArC), 137.7 
(Ar*C), 133.6 (CH, Bz), 130.1 (ArC), 129.7, 129.2, 128.5, 128.4, 127.7, 127.3 (1x ArCH, 
3x Ar*CH and 2x BzCH), 128.6 (C, Bz), 113.7 (ArCH), 82.7 (CH-7), 81.0 (CH-6), 78.3 
(CH-1), 73.4 (Ar*CH2), 72.7 (ArCH2), 70.4 (CH2OBn), 69.0 (CH-7a), 65.4 (CH2CH2O), 
63.4 (CH-5), 55.2 (OMe), 35.3 (CH2CH2O), 20.8 (CH3, Ac); MS (ES +ve) m/z 590 
(M+1+, 12%), 612 (M+Na+, 100%); HRMS (ES +ve) Calcd for C33H36NO9 (MH
+) 
590.2390, found: 590.2379. HRMS (EI +ve) Calcd for C33H35NO9 (M
+) 589.2312, found: 
589.2300. Spectral data for 18': 1H NMR (500 MHz)  7.91 (dd, 2H, J 8.0, 1.5 Hz, BzH), 
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7.60 (tt, 1H, J 7.5, 1.5 Hz, BzH), 7.43 (t, 2H, J 8.5 Hz, BzH), 7.20-7.13 (m, 7H, 2x ArH, 
5x Ar*H), 6.76 (d, 2H, J 9.0 Hz, ArH), 5.74 (dd, 1H, J 6.0, 2.0 Hz, H-6), 5.26 (dd, 1H, J 
4.0, 2.0 Hz, H-7), 4.53 (td, 1H, J 6.5, 4.0 Hz, H-1), 4.45-4.35 (m, 5H, ArCH2, Ar*CH2, 
H-5), 4.19 (t, 1H, J 4.0 Hz, H-7a), 3.71 (s, 3H, OMe), 3.80-3.57 (m, 4H, CH2OBn, 
CH2CH2O), 2.11 (s, 3H, Ac), 2.17-2.04 (m, 2H, CH2CH2O); 
13C NMR (125 MHz)  
169.6 (CO, Ac), 164.5 (CO, Bz), 160.9 (CO-3), 159.2 (ArC), 137.4 (Ar*C), 133.5 (CH, 
Bz), 131.5 (ArC), 129.7 (CH, Bz), 129.2, 128.5, 128.3, 127.6, 127.6 (1x ArCH, 3x 
Ar*CH, 1x BzCH), 129.0 (C, Bz), 113.7 (ArCH), 76.9 (CH-6), 75.8 (CH-7), 73.5, 73.0 
(ArCH2, Ar*CH2), 73.5 (CH-1), 67.3 (CH2OBn), 65.6 (CH2CH2O), 65.5 (CH-7a), 59.2 
(CH-5), 55.1 (OMe), 35.2 (CH2CH2O), 20.7 (CH3, Ac); MS (ES +ve) m/z 590 (M+1
+, 
13%), 612 (M+Na+, 100%); HRMS (ES +ve) Calcd for C33H36NO9 (MH
+) 590.2390, 
found: 590.2374. 
 
 
(-)-(1S,5R,6R,7R,7aS)-6-Acetoxy-1-(2-hydroxy)ethyl-7-phenylcarbonyloxy-5-
(phenylmethoxy)methyl-tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-one (19). The 
same procedure described above for the preparation of 11 was used starting with 18 (61 
mg, 0.104 mmol) and DDQ (33 mg, 0.146 mmol) in a solution of DCM (10 mL) 
containing water (0.5 mL). After the mixture had stirred at RT for 3 h, TLC analysis 
(60% EtOAc/petrol) indicated the presence of compound 18. Additional DDQ (14 mg, 
0.062 mmol) was then added to the mixture. The reaction was continued for another 1 h. 
Compound 19 (33 mg, 67%) was obtained as a pale yellow oil. []D24 -54.7 (c 1.6, 
CHCl3); 
1H NMR  7.96 (dt, 2H, J 8.4, 1.5 Hz, BzH), 7.62 (tt, 1H, J 7.5, 1.5 Hz, BzH), 
7.45 (t, 2H, J 7.8 Hz, BzH), 7.33-7.29 (m, 2H, Ar*H), 7.27-7.21 (m, 3H, Ar*H), 5.63 (dd, 
1H, J 3.0, 2.4 Hz, H-6), 5.15-5.09 (m, 2H, H-1, H-7), 4.61 (s, 2H, Ar*CH2), 4.16 (td, 1H, 
J 3.9, 2.4 Hz, H-5), 3.90-3.85 (m, 2H, H-7a, CHaCHbOBn), 3.82-3.80 (m, 2H, 
CH2CH2OH), 3.74 (dd, 1H, J 9.6, 4.2 Hz, CHaCHbOBn), 2.16-1.95 (m, 2H, CH2CH2OH), 
2.09 (s, 3H, Ac); 13C NMR  170.3 (CO, Ac), 166.5 (CO, Bz), 159.8 (CO-3), 137.6 
(Ar*C), 133.8, 129.8 (2x CH, Bz), 128.4 (C, Bz), 128.6, 128.4, 127.7, 127.3 (3x Ar*CH, 
1x BzCH), 83.3 (CH-7), 81.1 (CH-6), 78.5 (CH-1), 73.4 (Ar*CH2), 70.4 (CH2OBn), 69.2 
(CH-7a), 63.4 (CH-5), 58.5 (CH2CH2OH), 37.8 (CH2CH2OH), 20.8 (CH3, Ac); MS (ES 
24 
+ve) m/z 470 (M+1+, 8%), 492 (M+Na+, 100%); HRMS (ES +ve) Calcd for C25H28NO8 
(MH+) 470.1815, found: 470.1797.  
 
 
 
 (+)-(2S,3R,4R,5R)-5-[(1S)-1,3-Dihydroxypropyl]-2-(phenylmethoxy)methyl 
pyrrolizine-3,4-diol (20). The same procedure described above for the preparation of 12 
was used starting with 19 (32 mg, 0.067 mmol) and sodium hydroxide (427 mg, 0.674 
mmol) in a solution of ethanol (1 mL). Compound 20 (15 mg, 76%) was obtained as a 
pale yellow oil. []D25 +21.4 (c 1.5, MeOH); 1H NMR (CD3OD)  7.38-7.23 (m, 5H, 
Ar*H), 4.55 (s, 2H, Ar*CH2), 3.84-3.69 (m, 5H, H-3, H-4, CHOH, CH2CH2OH), 3.64 
(dd, 1H, J 9.6, 3.9 Hz, CHaCHbOBn), 3.51 (dd, 1H, J 9.6, 6.9 Hz, CHaCHbOBn), 3.10 (dt, 
1H, J 6.9, 3.6 Hz, H-2), 2.80 (dd, 1H, J 6.9, 5.4 Hz, H-5), 1.78 (dtd, 1H, J 14.1, 6.9, 3.6 
Hz, CHaCHbCH2OH), 1.65 (ddt, 1H, J 14.7, 9.0, 5.7 Hz, CHaCHbCH2OH); 
13C NMR 
(CD3OD )  139.6 (Ar*C), 129.4, 128.9, 128.7 (3x Ar*CH), 80.1, 80.0 (CH-3, CH-4), 
74.3 (Ar*CH2), 72.5 (CH2OBn), 69.7 (CHOH), 67.1 (CH-5), 62.3 (CH-2), 60.0 
(CH2CH2OH), 38.0 (CH2CH2OH); MS (ES +ve) m/z 298 (M+1
+, 100%); HRMS (ES 
+ve) Calcd for C15H24NO5 (MH
+) 298.1654, found: 298.1654.  
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